Investor Relations Regulatory Filings Board Decisions – 6th November 2024 Board Decisions – 13th August 2024 Investor Call Invite – 14th August 2024 Outcome of the Board Meeting – 30th May 2024 Transcript – Investor Call – 27th April 2024 Audio Recordings of Investors Call – 27th April 2024 Outcome of the Board Meeting- 26th April 2024 Investor Call Invite (revised) – 27th April 2024 Investor Call Invite – 27th April 2024 Investor Presentation – 26th April 2024 Reg 30 Disclosure – intimation of changes in senior management personnel – 19th March 2024 Investor Presentation – 8th February 2024 Press Release – 8th February 2024 Intimation of consideration of Interim Dividend Board Decisions – 08th Feb 2024 compliance under Reg 52_54 Investors Concall Invite Revised – 24th Jan 2024 – 3rd February 2024 Investors Concall Invite – 24th January 2024 Notice of Board Meeting – 17th January 2024 Reg_57(1)_Disclosure – 12th January 2024 Statement under Reg 13(3) for the quarter ended 31st December 2023 Reg 30 Disclosure_Intimation of change in shareholding in AHHL – 27th December 2023 Intimation of Trading Window – 22nd December 2023 Specification_Debt_ISIN_Details – 16th November 2023 Compliance under 52_54 – 9th November 2023 Statement under Regulation 13(3) for the quarter ended 30th September 2023 Notice of Record date Active ISIN-30th September 2023 Investor Presentation – 9th November 2023 Board Decisions – 9th November 2023 Investor Concall Invite – 3rd November 2023 Credit Rating Letter – 28th October 2023 Notice of the Board Meeting – 28th October 2023 Press Release – Kolkata – 27th September 2023 Intimation Trading Window – 26th September 2023 Reg 30 disclosure – Appointment of Senior Management Personnel 19th September 2023 Voting Results – AGM 30th August 2023 Investor Presentation – 11th August 2023 Board Decisions 11th August 2023 Investors Concall Invite – 9th August 2023 Notice of Board Meeting – 17th July 2023 compliance under Reg57(5) 3rd July 2023 Statement under Regulation 13(3) for the quarter ended 30th June 2023 caption Intimation of Trading Window_June 2023 compliance under Reg57(4) 21st June 2023 Intimation reg.change in AGM Date – 2nd June 2023 Outcome Analyst Call – 31st May 2023 Compliance Under 52_54 – 30th May 2023 Investor Presentation – 30th May 2023 Press Release – 30th May 2023 Investors call invite 25th May 2023 compliance under Reg57(4) 21st Mar 2023 Half Yearly Disclosures on RPT 31st March 2023 Statement under Regulation 13(3) for the quarter ended 31st Mar 2023 Intimation Trading Window – 27th Mar 2023 Secretarial Compliance Report – March 2023 compliance under Reg 57(5) March 2023 Annual Disclosure Large Entity March 2023 Outcome Analyst Call – 31st May 2023 Compliance Under 52_54 – 30th May 2023 Investor Presentation – 30th May 2023 Press Release – 30th May 2023 Investors call invite 25th May 2023 compliance under Reg57(4) 21st Mar 2023 Half Yearly Disclosures on RPT 31st March 2023 Statement under Regulation 13(3) for the quarter ended 31st Mar 2023 Board Decisions 30th May 2023 Notice of Board Meeting 8th May 2023 record date revised intimation 16th Feb 2023 Board Decisions – 14th February 2023 compliance under 52_54 – 14th Feb 2023 Investor Presentation – 14th Feb 2023 Notice of Board Meeting – 31st Jan 2023 compliance under Reg57(1) 12th Jan 2023 Statement under Regulation 13(3) for the quarter ended 31st Dec 2022 Intimation Trading Window – 26th Dec 2022 compliance under Reg57(4) 24th Dec 2022 Notice of Record Date 20th Dec 2022 Allotment of NCDs 14th Dec 2022 Notice of Unsecured Debentures 6th Dec 2022 Reg 30 disclosure – Letter of comfort – 6th Dec 2022 Board Decisions – 30th November 2022 Notice of the Board Meeting 26th November 2022 Half Yearly Disclosures on RPT 30th September 2022 Investor Presentation – 12th November 2022 Investors call invite 11th Nov 2022 Board Decisions – 10th November 2022 Investor Call Invite – 31st October 2022 Statement under Regulation 13(3) for the quarter ended 30th Sept 2022 Notice of the Board Meeting 14th October 2022 Intimation Acquisition of AyurVaid Hospitals Intimation Trading Window – 29th September 2022 Voting Results – AGM 25th August 2022 Investor Presentation – 12th August 2022 Board Decisions – 11th August 2022 Investor Call Invite – 9th August 2022 Acquisition of 650 bed hospital facility Gurgaon 8th August 2022 Notice of the Board Meeting 26th July 2022 Board Decisions – 16th July 2022 Statement under Regulation 13(3) for the quarter ended 30th June 2022 Intimation Trading Window – 27th June 2022 Investor Presentation – 26th May 2022 Board Decisions – 25th May 2022 Investor Call Invite – 23rd May 2022 Annual Disclosure – Large Entity- 14th May 2022 Initial Disclosure – Large Entity – 29th April 2022 Notice of the Board Meeting 25th April 2022 Statement under Regulation 13(3) for the quarter ended 31st March 2022 Half Yearly Disclosures on RPT 31st March 2022 Intimation Trading Window – 26th March 2022 Intimation effective date transfer of undertaking 16th March 2022 Intimation-Regulation 57(1) NCD payment 8th Mar 2022 Regulation 52(7) 14th Feb 2022 Investor Presentation 12th Feb 2022 Board Decisions – 11th February 2022 Investors call invite 10th Feb 2022 Investor Call Invite – 8th Feb 2022 Intimation Record NCD 5th Feb 2022 Investor Call Invite – 4th Feb 2022 Intimation credit rating 31st Jan 2022 Investors call invite 28th Jan 2022 Intimation upcoming launch amazon 28th Jan 2022 Notice of the Board Meeting 24th Jan 2022 Statement under Regulation 13(3) for the quarter ended 31st December 2021 Intimation of Closure of Trading Window 22nd Dec 2021 Voting Results Director appointment 21st Dec 2021 Notice of Postal Ballot 18th November 2021 Investor Presentation 13th November 2021 Board Decisions – 12th November 2021 Investors call invite 10th November 2021 Notice of the Board Meeting 25th Oct 2021 Statement under Regulation 13(3) for the quarter ended 30th September 2021 Half Yearly disclosures RPT 30th Sept 2021 Intimation of Closure of Trading Window 30th Sep 2021 Voting Results – AGM – 31st August 2021 Voting Results slumpsale backend pharmacy 14th August 2021 Investor Presentation 13th August 2021 Board Decisions – 13th August 2021 Investors call invite 12th August 2021 Notice of the Board Meeting 03rd August 2021 Board Decisions 21st July 2021 Notice of Postal Ballot 13th July 2021 QIP-PPD Jan 2021 Pharmacy Restructuring Execution of BTA – 1st July 2021 Intimation of Closure of Trading Window – 30th June 2021 Confirmation of order of Scheme of Amalgamation – 30th June 2021 Statement under Regulation 13(3) for the quarter ended 30th June 2021 Certificate under Regulation 52(5) 28th June 2021 Certificate compliance 57(2) 24th June 2021 Investor call invite presentation 23rd June 2021 Board Decisions – 23rd June 2021 Notice of the Board Meeting – 08th June 2021 Annual Disclosure – Large Entity – 15th May 2021 Voting Results – merger – 4th May 2021 Notice of acquisition – 22nd April 2021 Half Yearly Disclosures on RPT 31st March 2021 Statement under Regulation 13(3) for the quarter ended 31st March 2021 Notice of Postal Ballot – 31st March 2021 Board Decisions – 27th March 2021 Intimation of Record Date – 8th February 2021 Intimation – Scheme of Amalgamation – 28th January 2021 Notice of the Board Meeting – 28th January 2021 Committee Decisions – 23rd January 2021 Board Decisions – 18th January 2021 Notice of the Committee Meeting – 18th January 2021 Intimation of Notice of investor meetings – 11th January 2021 Intimation of Notice of investor meetings – 6th January 2021 Statement under Regulation 13(3) for the quarter ended 31 December 2020 Board Decisions – 2nd December 2020 Intimation of Closure of Trading Window – December 2020 Notice – 7th December 2020 Notice of the Board Meeting – 7th November 2020 Notice of the Board Meeting – 2nd November 2020 Half Yearly Disclosures on RPT-30th September 2020 Statement under Regulation 13(3) for the quarter ended 30th September 2020 Board Decisions – December 2020 Voting Results QIP 2020 Board Decision – November 2020 Intimation of Closure of Trading Window – September 2020 Voting Results 2020 Board Decision – September 2020 Half Yearly Disclosure on Related Party Transactions – 31st March 2020 Intimation of sanction of Scheme of Arrangement by NCLT Notice for Board Meeting Intimation of effective date of Scheme of Arrangement Call Option Notice – NCDs Intimation Record Date – NCDs Statement under Regulation 13(3) for the quarter ended 30th June 2020 Intimation of Closure of Trading Window – June 2020 Board Decisions – June 2020 Notice of Board Meeting – Revised Date Notice of Board Meeting Notice for Board Meeting Statement under Regulation 13(3) for the quarter ended 31st December 2019 Statement under Regulation 13(3) for the quarter ended 30th September 2019 Statement under Regulation 13(3) for the quarter ended 30th June 2019 Board Decisions – February 2020 Half Yearly Disclosure on Related Party Transactions – 30th September 2019 Board Decisions – November 2019 Board Decisions – August 2019 Half Yearly Disclosure on Related Party Transactions – 31st March 2019
